Vanda Pharmaceuticals Inc (VNDA)
5.47
+0.63
(+13.02%)
USD |
NASDAQ |
May 07, 16:00
5.52
+0.05
(+0.91%)
Pre-Market: 09:01
Vanda Pharmaceuticals Total Assets (Quarterly): 648.44M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 648.44M |
| September 30, 2023 | 641.60M |
| June 30, 2023 | 641.68M |
| March 31, 2023 | 644.53M |
| December 31, 2022 | 634.25M |
| September 30, 2022 | 621.79M |
| June 30, 2022 | 609.10M |
| March 31, 2022 | 603.56M |
| December 31, 2021 | 593.79M |
| September 30, 2021 | 579.77M |
| June 30, 2021 | 567.64M |
| March 31, 2021 | 543.19M |
| December 31, 2020 | 533.46M |
| September 30, 2020 | 515.90M |
| June 30, 2020 | 506.63M |
| March 31, 2020 | 488.52M |
| December 31, 2019 | 483.75M |
| September 30, 2019 | 474.45M |
| June 30, 2019 | 372.48M |
| March 31, 2019 | 351.17M |
| December 31, 2018 | 332.13M |
| September 30, 2018 | 311.94M |
| June 30, 2018 | 302.93M |
| March 31, 2018 | 317.32M |
| December 31, 2017 | 205.42M |
| Date | Value |
|---|---|
| September 30, 2017 | 205.71M |
| June 30, 2017 | 210.67M |
| March 31, 2017 | 204.72M |
| December 31, 2016 | 210.37M |
| September 30, 2016 | 208.44M |
| June 30, 2016 | 202.04M |
| March 31, 2016 | 206.74M |
| December 31, 2015 | 213.05M |
| September 30, 2015 | 220.54M |
| June 30, 2015 | 223.69M |
| March 31, 2015 | 213.64M |
| December 31, 2014 | 171.70M |
| September 30, 2014 | 79.18M |
| June 30, 2014 | 86.17M |
| March 31, 2014 | 120.98M |
| December 31, 2013 | 143.35M |
| September 30, 2013 | 155.09M |
| June 30, 2013 | 116.95M |
| March 31, 2013 | 125.14M |
| December 31, 2012 | 135.45M |
| September 30, 2012 | 149.81M |
| June 30, 2012 | 160.84M |
| March 31, 2012 | 172.60M |
| December 31, 2011 | 182.62M |
| September 30, 2011 | 195.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
372.48M
Minimum
Jun 2019
648.44M
Maximum
Dec 2023
563.40M
Average
579.77M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| ADMA Biologics Inc | 329.18M |
| INVO Bioscience Inc | 20.89M |
| Johnson & Johnson | 171.97B |
| Nektar Therapeutics | 398.03M |
| Invivyd Inc | 229.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 103.53M |
| Shareholders Equity (Quarterly) | 544.91M |
| Current Ratio | 4.937 |